Literature DB >> 33756228

Elevated linc00936 or silenced microRNA-425-3p inhibits immune escape of gastric cancer cells via elevation of ZC3H12A.

Haohao Li1, Chunlin Zhao1, Hongchao Zhao1, Guanghui Liu1, Haoxun Mao1, Yanfen Liu2.   

Abstract

OBJECTIVE: Gastric cancer (GC) is a malignant tumor originated from gastric mucosa. Without effective therapy, this study was to investigate the mechanism of long intergenic noncoding RNA 00936 (linc00936)/microRNA-425-3p (miR-425-3p)/monocyte chemotactic protein-induced protein 1 (ZC3H12A) axis mediating immune escape of GC cells.
METHODS: Peripheral blood samples, GC tissues and adjacent tissues were collected. The levels of CD3+, CD4+, and CD8+ in peripheral blood were detected. The expression levels of linc00936, miR-425-3p and ZC3H12A in GC tissues and cells were detected. The correlation between the expression of linc00936 in the tissues and the levels of CD3+, CD4+ and CD8+ in the peripheral blood of GC patients was analyzed. Cytokine-induced killer (CIK) cells were induced, and co-incubated with GC cells. BGC-823 and MKN-45 cells were screened and transfected with linc00936- or miR-425-3p-related oligonucleotides to figure out their roles in immune escape, migration, apoptosis and the cytotoxicity of CIK cells in GC cells.
RESULTS: Elevated miR-425-3p and reduced linc00936, and ZC3H12A expression levels were found in GC tissues and cells. Linc00936 expression was positively correlated with CD3+ and CD4+, and negatively correlated with CD8+ in peripheral blood of patients with GC. Up-regulating linc00936 or down-regulating miR-425-3p inhibited immune escape, migration, promoted apoptosis of GC cells, as well induced CIK cell cytotoxicity to GC cells. Down-regulated linc00936 or elevated miR-425-3p facilitated immune escape, migration, depressed apoptosis of GC cells, and reduced the cytotoxicity of CIK cells to GC cells.
CONCLUSION: The study concludes that up-regulated linc00936 or silenced miR-425-3p inhibits immune escape of GC cells via elevation of ZC3H12A.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cytotoxicity; Gastric cancer; Immune escape; Long intergenic noncoding RNA00936; MicroRNA-425-3p; Migration; Monocyte chemotactic protein-induced protein 1

Mesh:

Substances:

Year:  2021        PMID: 33756228     DOI: 10.1016/j.intimp.2021.107559

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

1.  Overexpression of LINC00936 Inhibits the Proliferation and Invasion of Endometrial Carcinoma Cells.

Authors:  Haizhu Sun; Peiling Li
Journal:  J Oncol       Date:  2022-05-31       Impact factor: 4.501

2.  Functional Screen for microRNAs Suppressing Anchorage-Independent Growth in Human Cervical Cancer Cells.

Authors:  Angelina Huseinovic; Annelieke Jaspers; Annina P van Splunter; Hanne Sørgård; Saskia M Wilting; Dorian R A Swarts; Ida H van der Meulen; Victor W van Beusechem; Renée X de Menezes; Renske D M Steenbergen
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

Review 3.  Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer.

Authors:  Ying Liu; Wei Ding; Wanpeng Yu; Yuan Zhang; Xiang Ao; Jianxun Wang
Journal:  Mol Ther Oncolytics       Date:  2021-11-11       Impact factor: 7.200

4.  Cancer cell-derived exosomal miR-425-3p induces white adipocyte atrophy.

Authors:  Anwen Liu; Wenxia Pan; Shutong Zhuang; Yuanzhi Tang; Haitao Zhang
Journal:  Adipocyte       Date:  2022-12       Impact factor: 3.553

5.  Circ_0007099 upregulates GNG7 to function as a tumor inhibitor in gastric carcinoma by interacting with miR-425-3p.

Authors:  Zhipeng Zhang; Yikai Zhou; Na Zhou; Junda Yin; Xuechun Kuang
Journal:  J Gastrointest Oncol       Date:  2022-08

6.  Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis.

Authors:  Tingting Sun; Jing Chen; Xuechao Sun; Guonian Wang
Journal:  Cancer Cell Int       Date:  2021-07-28       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.